AAAAAA

   
Results: 1-9 |
Results: 9
INTENSIVE TREATMENT IN ORDER TO MINIMIZE THE PH-POSITIVE CLONE IN CML
Authors: SIMONSSON B OBERG G LINDER O BJORKHOLM M CARNESKOG J STENKE L KARLE H LANNGNIELSEN J LOFVENBERG E MALM C PAUL C TURESSON I UDEN AM VILEN L WEISBJERRUM O
Citation: B. Simonsson et al., INTENSIVE TREATMENT IN ORDER TO MINIMIZE THE PH-POSITIVE CLONE IN CML, Blood, 90(10), 1997, pp. 1744-1744
INTENSIVE TREATMENT IN ORDER TO MINIMIZE THE PH-POSITIVE CLONE IN CML
Authors: SIMONSSON B OBERG G BJOREMAN M BJORKHOLM M CARNESKOG J GAHRTON G HAST R KARL H LANNGNIELSEN J LOFVENBERG E MALM C TURESSON I UDEN AM VILEN L WEISBJERRUM O
Citation: B. Simonsson et al., INTENSIVE TREATMENT IN ORDER TO MINIMIZE THE PH-POSITIVE CLONE IN CML, Bone marrow transplantation, 17, 1996, pp. 63-64
A PHASE-I II STUDY OF SDZ PSC-833 (PSC) IN COMBINATION WITH DAUNORUBICIN (D) AND CYTARABINE IN REFRACTORY ACUTE MYELOGENOUS LEUKEMIA (AML)/
Authors: LILIEMARK J BJORKHOLM M UDEN AM HAST R PAUL C SIMONSSON B TIDEFELT U JULIUSSON G HEDENUS M EVENSEN S TANGEN JM SJO M NESTHUS I HESTDAL K
Citation: J. Liliemark et al., A PHASE-I II STUDY OF SDZ PSC-833 (PSC) IN COMBINATION WITH DAUNORUBICIN (D) AND CYTARABINE IN REFRACTORY ACUTE MYELOGENOUS LEUKEMIA (AML)/, Blood, 88(10), 1996, pp. 854-854
MITOXANTRONE, ETOPOSIDE AND ARA-C VS DOXORUBICIN-DNA, ARA-C, THIOGUANINE, VINCRISTINE AND PREDNISOLONE IN THE TREATMENT OF PATIENTS WITH ACUTE MYELOCYTIC-LEUKEMIA - A RANDOMIZED COMPARISON
Authors: BJORKHOLM M LILIEMARK J GAHRTON G GRIMFORS G GRUBER A HAST R JULIUSSON G JARNMARK M KILLANDER A KIMBY E LERNER R LJUNGMAN P LONNQVIST B PALMBLAD J PAUL C PETTERSON C SIMONSSON B STALFELT AM STENKE L SUNDSTROM C TIDEFELT U UDEN AM OBERG G OST A
Citation: M. Bjorkholm et al., MITOXANTRONE, ETOPOSIDE AND ARA-C VS DOXORUBICIN-DNA, ARA-C, THIOGUANINE, VINCRISTINE AND PREDNISOLONE IN THE TREATMENT OF PATIENTS WITH ACUTE MYELOCYTIC-LEUKEMIA - A RANDOMIZED COMPARISON, European journal of haematology, 55(1), 1995, pp. 19-23
CHLORAMBUCIL PREDNISONE VS CHOP IN SYMPTOMATIC LOW-GRADE NON-HODGKINS-LYMPHOMAS - A RANDOMIZED TRIAL FROM THE LYMPHOMA-GROUP-OF-CENTRAL-SWEDEN
Authors: KIMBY E BJORKHOLM M GAHRTON G GLIMELIUS B HAGBERG H JOHANSSON B JOHANSSON H JULIUSSON G JARNMARK M LOFVENBERG E KILLANDER A LERNER R LINDEMALM C PETTERSSON U ROBERT KH SIMONSSON B STALFELT AM SUNDSTROM C SVEDMYR E UDEN AM WADMAN B WAHLIN A OST A MELLSTEDT H
Citation: E. Kimby et al., CHLORAMBUCIL PREDNISONE VS CHOP IN SYMPTOMATIC LOW-GRADE NON-HODGKINS-LYMPHOMAS - A RANDOMIZED TRIAL FROM THE LYMPHOMA-GROUP-OF-CENTRAL-SWEDEN, Annals of oncology, 5, 1994, pp. 190000067-190000071
INTENSIVE TREATMENT IN ORDER TO MINIMIZE THE PH-POSITIVE CLONE IN CHRONIC MYELOGENIC LEUKEMIA (CML)
Authors: SIMONSSON B OBERG G KILLANDER A BJOREMAN M BJORKHOLM M GAHRTON G STENKE L TURESSON I UDEN AM MALM C VILEN L WAHLIN A LOFVENBERG E CARNESKOG J WESTIN J
Citation: B. Simonsson et al., INTENSIVE TREATMENT IN ORDER TO MINIMIZE THE PH-POSITIVE CLONE IN CHRONIC MYELOGENIC LEUKEMIA (CML), Bone marrow transplantation, 14, 1994, pp. 55-56
ALPHA-INTERFERON (WELLFERON), CYCLOPHOSPHAMIDE AND HIGH-DOSE BETAMETHASONE (CIB) FOLLOWED BY GM-CSF FOR TREATMENT OF MULTIPLE-MYELOMA - A PILOT-STUDY
Authors: OSTERBORG A BJORKHOLM M BJOREMAN M BRENNING G CARLSON K CELSING F GAHRTON G GRIMFORS G GYLLENHAMMAR H HAST R JOHANSSON B JULIUSSON G JARNMARK M KIMBY E LERNER R LINDEMALM C LINDER O OHRLING M PAUL C SIMONSSON B SKARBERG KF SMEDMYR B STRANDER H SVEDMYR E TIDEFELT U UDEN AM WERNER B OSBY E MELLSTEDT H
Citation: A. Osterborg et al., ALPHA-INTERFERON (WELLFERON), CYCLOPHOSPHAMIDE AND HIGH-DOSE BETAMETHASONE (CIB) FOLLOWED BY GM-CSF FOR TREATMENT OF MULTIPLE-MYELOMA - A PILOT-STUDY, Blood, 84(10), 1994, pp. 10000657-10000657
INTENSIVE TREATMENT IN ORDER TO MINIMIZE THE PH-POSITIVE CLONE IN CHRONIC MYELOGENIC LEUKEMIA
Authors: SIMONSSON B OBERG G KILLANDER A BJOREMAN M BJORKHOLM M GAHRTON G HAST R TURESSON I UDEN AM MALM C VILEN L WAHLIN A LOFVENBERG E CARNESKOG J WESTIN J
Citation: B. Simonsson et al., INTENSIVE TREATMENT IN ORDER TO MINIMIZE THE PH-POSITIVE CLONE IN CHRONIC MYELOGENIC LEUKEMIA, Stem cells, 11, 1993, pp. 73-76
ETOPOSIDE, DOXORUBICIN, CYCLOPHOSPHAMIDE AND HIGH-DOSE BETAMETHASONE (EACB) AS OUTPATIENT SALVAGE THERAPY FOR REFRACTORY MULTIPLE-MYELOMA
Authors: OHRLING M BJORKHOLM M OSTERBORG A JULIUSSON G BJOREMAN M BRENNING G CARLSON K CELSING F GAHRTON G GRIMFORS G GRUBER A GYLLENHAMMAR H HAST R JOHANSSON B JARNMARK M KIMBY E LERNER R LINDER O MERK K PAUL C SIMONSSON B SMEDMYR B SVEDMYR E STALFELT AM UDEN AM OSBY E MELLSTEDT H
Citation: M. Ohrling et al., ETOPOSIDE, DOXORUBICIN, CYCLOPHOSPHAMIDE AND HIGH-DOSE BETAMETHASONE (EACB) AS OUTPATIENT SALVAGE THERAPY FOR REFRACTORY MULTIPLE-MYELOMA, European journal of haematology, 51(1), 1993, pp. 45-49
Risultati: 1-9 |